Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lamoreaux

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanningRobert J Myerson, Anurag K Singh, Heather M Bigott, et al.
Arthritis Research & Therapy|August 25, 2022
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label studyJohn K Botson, John R P Tesser, Ralph Bennett, et al.
International Journal of Molecular Sciences|June 3, 2014
Gamma knife treatment of brainstem metastasesHalloran E Peterson, Erik W Larson, Robert K Fairbanks, et al.
Journal of Virology|February 1, 2008
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cellsMarybeth Daucher, David A Price, Jason M Brenchley, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|March 27, 2020
Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Plos One|February 4, 2010
Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesRichard A Koup, Mario Roederer, Laurie Lamoreaux, et al.
Case Reports in Neurological Medicine|November 25, 2015
Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell CarcinomaEthan A Ferrel, Andrew T Roehrig, Wayne T Lamoreaux, et al.
Plos One|September 8, 2023
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular riskRyan E Feaver, M Scott Bowers, Banumathi K Cole, et al.
Physical Review Letters|September 28, 2004
Neutron-detected tomography of impurity-seeded superfluid heliumM E Hayden, G Archibald, P D Barnes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 13, 2022
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety FindingsJohn K Botson, Kenneth Saag, Jeff Peterson, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanningRobert J Myerson, Anurag K Singh, Heather M Bigott, et al.
Arthritis Research & Therapy|August 25, 2022
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label studyJohn K Botson, John R P Tesser, Ralph Bennett, et al.
International Journal of Molecular Sciences|June 3, 2014
Gamma knife treatment of brainstem metastasesHalloran E Peterson, Erik W Larson, Robert K Fairbanks, et al.
Journal of Virology|February 1, 2008
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cellsMarybeth Daucher, David A Price, Jason M Brenchley, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|March 27, 2020
Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Plos One|February 4, 2010
Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesRichard A Koup, Mario Roederer, Laurie Lamoreaux, et al.
Case Reports in Neurological Medicine|November 25, 2015
Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell CarcinomaEthan A Ferrel, Andrew T Roehrig, Wayne T Lamoreaux, et al.
Plos One|September 8, 2023
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular riskRyan E Feaver, M Scott Bowers, Banumathi K Cole, et al.
Physical Review Letters|September 28, 2004
Neutron-detected tomography of impurity-seeded superfluid heliumM E Hayden, G Archibald, P D Barnes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 13, 2022
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety FindingsJohn K Botson, Kenneth Saag, Jeff Peterson, et al.
Pageof 22